Kura Oncology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $53,883 | $0 | $0 | $0 |
Gross Profit | 53,883 | -202 | -234 | |
EBITDA | -16,592 | -59,676 | -50,229 | -48,893 |
EBIT | -16,796 | -59,884 | -50,431 | -49,127 |
Net Income | -19,217 | -54,404 | -50,837 | -49,525 |
Net Change In Cash | 53,883 | 0 | 0 | 0 |
Free Cash Flow | 268,759 | -43,440 | -42,546 | -48,928 |
Cash | 224,462 | 49,480 | 45,183 | 41,506 |
Basic Shares | 87,136 | 86,950 | 86,635 | 83,905 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $53,883 | $0 | $0 | $0 |
Gross Profit | 53,883 | -849 | -759 | -558 |
EBITDA | -169,498 | -164,955 | -139,106 | -129,706 |
EBIT | -170,346 | -165,804 | -139,865 | -130,264 |
Net Income | -173,983 | -152,631 | -136,069 | -129,908 |
Net Change In Cash | 53,883 | 0 | 0 | 0 |
Cost of Revenue | -38,870 | -234,821 | ||
Free Cash Flow | 133,845 | -124,992 | -110,688 | -105,698 |
Cash | 224,462 | 37,318 | 51,802 | 90,672 |
Basic Shares | 86,161 | 73,229 | 66,989 | 66,352 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.22 |
2024-09-30 | -$0.63 |
2024-06-30 | -$0.59 |
2024-03-31 | -$0.59 |
